Marketable Securities, Current of Enlivex Therapeutics Ltd. from 30 Jun 2021 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Enlivex Therapeutics Ltd. quarterly Marketable Securities, Current in USD history and change rate from 30 Jun 2021 to 30 Jun 2025.
Enlivex Therapeutics Ltd. Marketable Securities, Current for the quarter ending 30 Jun 2025 was $6,000, a 97% decline year-over-year.
Source SEC data: View on sec.gov

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Change (%)

Enlivex Therapeutics Ltd. Quarterly Marketable Securities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$6,000	-$222,000	-97%	30 Jun 2025	6-K	29 Aug 2025	2025	Q2
Q4 2024	$198,000	-$4,910,000	-96%	31 Dec 2024	6-K	29 Aug 2025	2025	Q2
Q2 2024	$228,000			30 Jun 2024	6-K	30 Aug 2024	2024	Q2
Q4 2023	$5,108,000			31 Dec 2023	20-F	30 Apr 2025	2024	FY
Q4 2021	$62,924,000			31 Dec 2021	20-F	10 Apr 2023	2022	FY
Q2 2021	$67,964,000			30 Jun 2021	6-K	06 Aug 2021	2021	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.